BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30382369)

  • 1. First experience and clinical results using a new non-coplanar mono-isocenter technique (HyperArc™) for Linac-based VMAT radiosurgery in brain metastases.
    Alongi F; Fiorentino A; Gregucci F; Corradini S; Giaj-Levra N; Romano L; Rigo M; Ricchetti F; Beltramello A; Lunardi G; Mazzola R; Ruggieri R
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):193-200. PubMed ID: 30382369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc™) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis.
    Nicosia L; Figlia V; Mazzola R; Napoli G; Giaj-Levra N; Ricchetti F; Rigo M; Lunardi G; Tomasini D; Bonù ML; Corradini S; Ruggieri R; Alongi F
    Clin Exp Metastasis; 2020 Feb; 37(1):77-83. PubMed ID: 31691873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic ablative radiation therapy for brain metastases with volumetric modulated arc therapy and flattening filter free delivery: feasibility and early clinical results.
    Fiorentino A; Giaj-Levra N; Tebano U; Mazzola R; Ricchetti F; Fersino S; Di Paola G; Aiello D; Ruggieri R; Alongi F
    Radiol Med; 2017 Sep; 122(9):676-682. PubMed ID: 28447313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linac-based radiosurgery or fractionated stereotactic radiotherapy with flattening filter-free volumetric modulated arc therapy in elderly patients : A mono-institutional experience on 110 brain metastases.
    Gregucci F; Fiorentino A; Corradini S; Figlia V; Mazzola R; Ricchetti F; Ruggieri R; Alongi F
    Strahlenther Onkol; 2019 Mar; 195(3):218-225. PubMed ID: 30478669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linac-based VMAT radiosurgery for multiple brain lesions: comparison between a conventional multi-isocenter approach and a new dedicated mono-isocenter technique.
    Ruggieri R; Naccarato S; Mazzola R; Ricchetti F; Corradini S; Fiorentino A; Alongi F
    Radiat Oncol; 2018 Mar; 13(1):38. PubMed ID: 29506539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term disease outcome and volume-based decision strategy in a large cohort of multiple brain metastases treated with a mono-isocentric linac-based Stereotactic Radiosurgery technique.
    Alongi F; Nicosia L; Figlia V; Giaj-Levra N; Cuccia F; Mazzola R; Ricchetti F; Rigo M; Vitale C; De Simone A; Naccarato S; Sicignano G; Gurrera D; Corradini S; Ruggeri R
    Clin Transl Oncol; 2021 Aug; 23(8):1561-1570. PubMed ID: 33570720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of Linac-based single-isocenter non-coplanar technique (HyperArcTM) for brain metastases radiosurgery.
    Alongi F; Fiorentino A; Ruggieri R; Ricchetti F; Kupelian P
    Clin Exp Metastasis; 2018 Oct; 35(7):601-603. PubMed ID: 30143886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Bunevicius A; Fribance S; Pikis S; Lee JYK; Buch LY; Moran M; Yang AI; Bernstein K; Mathieu D; Perron R; Liscak R; Simonova G; Patel S; Trifiletti DM; Martínez Álvarez R; Martínez Moreno N; Lee CC; Yang HC; Strickland BA; Zada G; Chang EL; Kondziolka D; Sheehan J
    Thyroid; 2021 Aug; 31(8):1244-1252. PubMed ID: 33978475
    [No Abstract]   [Full Text] [Related]  

  • 10. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
    Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINAC based stereotactic radiosurgery for multiple brain metastases: guidance for clinical implementation.
    Hartgerink D; Swinnen A; Roberge D; Nichol A; Zygmanski P; Yin FF; Deblois F; Hurkmans C; Ong CL; Bruynzeel A; Aizer A; Fiveash J; Kirckpatrick J; Guckenberger M; Andratschke N; de Ruysscher D; Popple R; Zindler J
    Acta Oncol; 2019 Sep; 58(9):1275-1282. PubMed ID: 31257960
    [No Abstract]   [Full Text] [Related]  

  • 15. Volumetric modulated arc radiosurgery for brain metastases from breast cancer: A single-center study.
    Sánchez-Villalobos JM; Serna-Berna A; Salinas-Ramos J; Escolar-Pérez PP; Martínez-Alonso E; Achel DG; Alcaraz M
    Colomb Med (Cali); 2021; 52(3):e2004567. PubMed ID: 35382414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
    Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
    Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.
    Shultz DB; Modlin LA; Jayachandran P; Von Eyben R; Gibbs IC; Choi CYH; Chang SD; Harsh GR; Li G; Adler JR; Hancock SL; Soltys SG
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):993-999. PubMed ID: 26194677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated stereotactic radiotherapy for brain metastases from lung cancer : Evaluation of indications and predictors of local control.
    Ishihara T; Yamada K; Harada A; Isogai K; Tonosaki Y; Demizu Y; Miyawaki D; Yoshida K; Ejima Y; Sasaki R
    Strahlenther Onkol; 2016 Jun; 192(6):386-93. PubMed ID: 27169391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.